References
- Balasubramanian S, Eckert RL (2007). Keratinocyte proliferation, differentiation, and apoptosis-differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharmacol, 224, 214-9. https://doi.org/10.1016/j.taap.2007.03.020
- Barsyte-Lovejoy D, Lau SK, Boutros PC, et al (2006). The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res, 66, 5330-7. https://doi.org/10.1158/0008-5472.CAN-06-0037
- Berteaux N, Lottin S, Monte D, et al (2005). H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem, 280, 29625-36. https://doi.org/10.1074/jbc.M504033200
- Burk U, Schubert J, Wellner U, et al (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep, 9, 582-9. https://doi.org/10.1038/embor.2008.74
- Cesana M, Cacchiarelli D, Legnini I, et al (2011). A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell, 147, 358-69. https://doi.org/10.1016/j.cell.2011.09.028
- Chen L-L, Carmichael GG (2009). Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: Functional role of a nuclear noncoding RNA. Mol Cell, 35, 467-78. https://doi.org/10.1016/j.molcel.2009.06.027
- Chen L-L, Carmichael GG (2010). Decoding the function of nuclear long non-coding RNAs. Curr Opin Cell Biol, 22, 357-64. https://doi.org/10.1016/j.ceb.2010.03.003
- Chen W, Bocker W, Brosius J, et al (1997). Expression of neural BC200 RNA in human tumours. J Pathol, 183, 345-51. https://doi.org/10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8
- Clemson CM, Hutchinson JN, Sara SA, et al (2009). An Architectural Role for a Nuclear Noncoding RNA: NEAT1 RNA Is Essential for the Structure of Paraspeckles. Mol cell, 33, 717-26. https://doi.org/10.1016/j.molcel.2009.01.026
- Clemson CM, McNeil JA, Willard HF, et al (1996). XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. J Cell Biol, 132, 259-75. https://doi.org/10.1083/jcb.132.3.259
- Coccia EM, Cicala C, Charlesworth A, et al (1992). Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation and development. Mol Cell Biol, 12, 3514-21.
- Fejes-Toth K, Sotirova V, Sachidanandam R, et al (2009). Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs. Nature, 457, 1028-32. https://doi.org/10.1038/nature07759
- Fellig Y, Ariel I, Ohana P, et al (2005). H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol, 58, 1064-8. https://doi.org/10.1136/jcp.2004.023648
- Flynn RA , Chang HY (2012). Active chromatin and noncoding RNAs: an intimate relationship. Curr Opin Gene Dev, 22, 172-8. https://doi.org/10.1016/j.gde.2011.11.002
- Fox AH, Bond CS, Lamond AI (2005). P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an RNA-dependent manner. Mol Biol Cell, 16, 5304-15. https://doi.org/10.1091/mbc.E05-06-0587
- Gabory A, Jammes H, Dandolo L (2010). The H19 locus: Role of an imprinted non-coding RNA in growth and development. Bioessays, 32, 473-80. https://doi.org/10.1002/bies.200900170
- Giannoukakis N, Deal C, Paquette J, et al (1993). Parental genomic imprinting of the human IGF2 gene. Nat Genet, 4, 98-101. https://doi.org/10.1038/ng0593-98
- Gupta RA, Shah N, Wang KC, et al (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464, 1071-6. https://doi.org/10.1038/nature08975
- Hassan S, Buchanan M, Jahan K, et al (2011). CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. Int J Cancer, 129, 225-32. https://doi.org/10.1002/ijc.25665
- Hibi K, Nakamura H, Hirai A, et al (1996). Loss of H19 imprinting in esophageal cancer. Cancer Res, 56, 480-2.
- Hu Q, Chen WX, Zhong SL, et al (2013). Current progress in the treatment of metaplastic breast carcinoma. Asian Pac J Cancer P, 14, 6221-5. https://doi.org/10.7314/APJCP.2013.14.11.6221
- Hung T, Wang Y, Lin MF, et al (2011). Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet, 43, 621-9. https://doi.org/10.1038/ng.848
- Hutvagner G, Zamore PD (2002). A microRNA in a multipleturnover RNAi enzyme complex. Science, 297, 2056-60. https://doi.org/10.1126/science.1073827
- Kino T, Hurt DE, Ichijo T, et al (2010). Noncoding RNA gas5 is a growth arrest-and starvation-associated repressor of the glucocorticoid receptor. Sci Signal, 3, ra8.
- Lai EC (2002). MicroRNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet, 30, 363.2. https://doi.org/10.1038/ng865
- Lottin S, Adriaenssens E, Dupressoir T, et al (2002). Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis, 23, 1885-95. https://doi.org/10.1093/carcin/23.11.1885
- Lv J, Yu YQ, Li SQ, et al (2014). Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1. Asian Pac J Cancer Prev, 15, 2565-70. https://doi.org/10.7314/APJCP.2014.15.6.2565
- Matouk IJ, DeGroot N, Mezan S, et al (2007). The H19 noncoding RNA is essential for human tumor growth. PLoS One, 2, e845. https://doi.org/10.1371/journal.pone.0000845
- Mourtada-Maarabouni M, Pickard M, Hedge V, et al (2009). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene, 28, 195-208. https://doi.org/10.1038/onc.2008.373
- Olson P, Lu J, Zhang H, et al (2009). MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Gene Dev, 23, 2152-65. https://doi.org/10.1101/gad.1820109
- Pei CH, Wu HY, Fan FT, et al (2014). Influence of curcumin on HOTAIR-mediated migration of human renal cell carcinoma cell. Asian Pac J Cancer Prev, 15, 4239-43. https://doi.org/10.7314/APJCP.2014.15.10.4239
- Ponting CP, Belgard TG (2010). Transcribed dark matter: meaning or myth? Hum Mol Genet, 19, R162-8. https://doi.org/10.1093/hmg/ddq362
- Qiao HP, Gao WH, Huo JX, et al (2013). Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prev, 14, 1077-82. https://doi.org/10.7314/APJCP.2013.14.2.1077
- Rinn JL, Kertesz M, Wang JK, et al (2007). Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell, 129, 1311-23. https://doi.org/10.1016/j.cell.2007.05.022
- Sasaki Y, Hiro se T, et al (2009), How to build a paraspeckle. Genome Biol, 10, 227. https://doi.org/10.1186/gb-2009-10-7-227
- Schneider C, King RM, Philipson L et al (1988). Genes specifically expressed at growth arrest of mammalian cells. Cell, 54, 787-93. https://doi.org/10.1016/S0092-8674(88)91065-3
- Silva JM, Boczek NJ, Berres MW et al(2011).LSINCT 5 is overexpressed in breast and ovarian cancer and affects cellular proliferation. Rna Bilo, 8, 496-505. https://doi.org/10.4161/rna.8.3.14800
- Smaldone MC, Davies BJ, et al (2010). BC-819 a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. Curr Opin Mol Ther, 12, 607-16.
-
Sunwoo H, Dinger ME, Wilusz JE, et al (2009). MEN
$\varepsilon$ /$\beta$ nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res, 19, 347-59. - Swanton C, Caldas C (2009). Molecular classification of solid tumours: towards pathway-driven therapeutics. Brit J Cancer, 100, 1517-22. https://doi.org/10.1038/sj.bjc.6605031
- Szymanski M, Barciszewski J (2006). RNA regulation in mammals. Ann NY Acad Sci, 1067, 461-8. https://doi.org/10.1196/annals.1354.066
- Tsai M-C, Manor O, Wan Y, et al (2010). Long noncoding RNA as modular scaffold of histone modification complexes. Science, 329, 689-93. https://doi.org/10.1126/science.1192002
- Tsai M-C, Spitale RC, Chang HY (2011). Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res, 71, 3-7.
- Tsang WP, Ng EK, Ng SS, et al (2010). Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis, 31, 350-8. https://doi.org/10.1093/carcin/bgp181
- Wan Yue, Howar Y (2010). Flight of noncoding RNAs in cancer metastasis. Cell Cycle, 9, 3391-2. https://doi.org/10.4161/cc.9.17.13122
- Wang J, Liu X, Wu H, et al (2010). CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res, 38, 5366-83. https://doi.org/10.1093/nar/gkq285
- Wang KC, Chang HY (2011). Molecular mechanisms of long noncoding RNAs. Mol Cell, 43, 904-14. https://doi.org/10.1016/j.molcel.2011.08.018
- Wapinski O, Chang HY (2011). Long noncoding RNAs and human disease. Trends Cell Biol, 21, 354-61. https://doi.org/10.1016/j.tcb.2011.04.001
- Wilusz JE, Sunwoo H, Spector DL (2009). Long noncoding RNAs: functional surprises from the RNA world. Gene Dev, 23, 1494-504. https://doi.org/10.1101/gad.1800909
- Yang tao, Li jun tang, Wang li juan, et al (2012). The influence of interference IncRNAs HOTAIR in human breast cancer cells MDA-MB-231. Chin J Cell Mol Immunol, 28, 97-8.
- Yan L-X, Huang X-F, Shao Q, et al (2008). MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 14, 2348-60. https://doi.org/10.1261/rna.1034808
- Zemel S, Bartolomei MS, Tilghman SM (1992). Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nat Genet, 2, 61-5. https://doi.org/10.1038/ng0992-61
- Zeng Y, Yi R, Cullen BR (2003). MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA, 100, 9779-84. https://doi.org/10.1073/pnas.1630797100
- Zhang Y, Tycko B (1992). Monoallelic expression of the human H19 gene. Nat Genet, 1, 40-44. https://doi.org/10.1038/ng0492-40
Cited by
- Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer vol.26, pp.9, 2016, https://doi.org/10.1097/IGC.0000000000000828
- A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4572-y
- LncRNAs: key players and novel insights into cervical cancer vol.37, pp.3, 2016, https://doi.org/10.1007/s13277-015-4663-9
- Long Non-Coding RNA CCAT1 Acts as a Competing Endogenous RNA to Regulate Cell Growth and Differentiation in Acute Myeloid Leukemia vol.39, pp.4, 2016, https://doi.org/10.14348/molcells.2016.2308
- Multiple Functions of Long Non-Coding RNAs in Oxidative Stress, DNA Damage Response and Cancer Progression vol.119, pp.1, 2017, https://doi.org/10.1002/jcb.26217
- in HER2-positive breast cancer cells vol.39, pp.6, 2017, https://doi.org/10.1177/1010428317707374
- Emerging ways to treat breast cancer: will promises be met? pp.2211-3436, 2018, https://doi.org/10.1007/s13402-018-0409-1
- Microarray expression profiling and co-expression network analysis of circulating LncRNAs and mRNAs associated with neurotoxicity induced by BPA vol.25, pp.15, 2018, https://doi.org/10.1007/s11356-018-1678-y
- Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway pp.00219541, 2019, https://doi.org/10.1002/jcp.28007
- Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer pp.15821838, 2019, https://doi.org/10.1111/jcmm.14200